Literature DB >> 33245354

Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic.

Sahar Bajis1, Tanya L Applegate1, Jason Grebely1, Gail V Matthews1, Gregory J Dore1.   

Abstract

The World Health Organization has set a goal to eliminate hepatitis C virus (HCV) infection as public health threat by 2030. Although the advent of highly effective and tolerable direct-acting antiviral therapy has paved the way for HCV elimination, most people with HCV infection remain undiagnosed and untreated globally, with striking disparities between high-income and low- to middle-income countries. Novel decentralized and cost-effective "test-and-treat" strategies are critically needed to identify the millions of people unaware of their status and link them to treatment.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HCV; HCV elimination; direct-acting antivirals; global health; testing strategies

Year:  2020        PMID: 33245354     DOI: 10.1093/infdis/jiaa366

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study.

Authors:  Mohammad Tasavon Gholamhoseini; Heidar Sharafi; Helena Hl Borba; Seyed Moayed Alavian; Asma Sabermahani; Behzad Hajarizadeh
Journal:  BMJ Open       Date:  2022-06-08       Impact factor: 3.006

2.  Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).

Authors:  Daniel O'Keefe; J Gunn; Kathleen Ryan; Filip Djordjevic; Phoebe Kerr; Judy Gold; Imogen Elsum; Chloe Layton; Kico Chan; Paul Dietze; Peter Higgs; Joseph Doyle; Mark A Stoové; Margaret Hellard; A E Pedrana
Journal:  BMJ Open       Date:  2022-01-04       Impact factor: 2.692

3.  Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.

Authors:  Mohammad T Yousafzai; Maryam Alavi; Heather Valerio; Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.